An NHS initiative conducted routine blood tests on individuals arriving at emergency departments, uncovering over 4,000 cases of undiagnosed hepatitis B and C, which can lead to liver cirrhosis. The UK Health Security Association disclosed the outcomes of its bloodborne virus (BBV) testing program at 34 A&Es in regions with the highest HIV prevalence as part of the government’s effort to eliminate new HIV transmissions by 2030. Among those tested, one in every 2,000 individuals had HIV, with half of them in advanced stages of the disease.
Public Health Minister Ashley Dalton praised the program’s success in identifying infections that would have otherwise gone unnoticed. By integrating testing into emergency care routines, patients can access life-saving treatment sooner, benefiting both individuals and the wider community. The initiative aligns with the goal of ending new HIV transmissions by 2030 through enhanced testing and treatment accessibility, ensuring that every newly diagnosed individual receives the necessary care.
HIV is a virus that attacks the immune system and can progress to AIDS without treatment. While there is no definitive cure, the NHS emphasizes that proper medical management can effectively control the virus. Hepatitis, which affects the liver and can lead to cirrhosis and liver cancer, was detected in one in 240 individuals with hepatitis B and one in 1,276 with hepatitis C among those tested.
Under the BBV program, A&E patients were automatically screened for HIV, hepatitis B, and hepatitis C unless they chose to opt out, with a 70% acceptance rate among eligible individuals. Over the initial 33 months, the initiative identified various infections in patients who were subsequently offered life-saving treatment.
Dr. Claire Fuller, NHS England medical director, commended the deployment of blood-borne virus testing in NHS emergency departments for its pivotal role in early HIV and viral hepatitis detection, enabling more individuals to access life-saving treatments and reduce long-term health complications while curbing virus transmission.
Dr. Sema Mandal, Consultant Epidemiologist and deputy director at the UKHSA, highlighted the impact of the NHS opt-out testing program in emergency departments, reaching thousands of previously undiagnosed individuals with HIV, hepatitis B, or hepatitis C. The initiative underscores the pressing need to address these serious infections by enhancing awareness, expanding testing and diagnosis, and ensuring individuals receive proper care and treatment. Early diagnosis can prevent long-term health issues and save numerous lives.